President Paul Kagame received Amb. Minata Samaté Cessouma, African Union Commissioner for Health, Humanitarian Affairs, and Social Development, and Dr. Jean Kaseya, Director-General of the Africa Centres for Disease Control and Prevention (AfricaCDC) at Village Urugwiro on Friday, November 1st. Amb. Minata Samaté Cessouma is in Kigali for the morning's inauguration of the new African Medicines Agency (AMA) headquarters. "President Kagame reaffirmed Rwanda’s commitment to the delivery of equitable access to quality medical products and technologies across the continent," the office of the Pres
President Paul Kagame received Amb. Minata Samaté Cessouma, African Union Commissioner for Health, Humanitarian Affairs, and Social Development, and Dr. Jean Kaseya, Director-General of the Africa Centres for Disease Control and Prevention (AfricaCDC) at Village Urugwiro on Friday, November 1st.
Amb. Minata Samaté Cessouma is in Kigali for the morning's inauguration of the new African Medicines Agency (AMA) headquarters.
"President Kagame reaffirmed Rwanda’s commitment to the delivery of equitable access to quality medical products and technologies across the continent," the office of the President posted on X.

President Paul Kagame received Amb. Minata Samaté Cessouma, African Union Commissioner for Health, Humanitarian Affairs, and Social Development.

President Kagame also received Dr. Jean Kaseya, Director General of the Africa CDC.
In the morning of this Friday, Rwanda's Minister of Health, Dr. Nsanzimana Sabin, and Amb. Minata SAMATE CESSOUMA, the Commissioner for Health and Social Development at the African Union, inaugurated the new Africa Medicines Agency (AMA) headquarters in Rwanda, marking a significant milestone for healthcare on the continent.
The handover included a fully equipped building, vehicles, and essential resources to support AMA's mission. Selected as the host nation at the 2022 AU Summit, Rwanda will facilitate AMA’s pivotal role in standardizing and regulating medicines across Africa.




Comments
No comments yet. Be the first to share a thought.